We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Über IASLC Staging Handbook

IASLC Staging Handbook in Thoracic Oncology

Presents IASLC-recommended changes for lung cancer staging in the UICC and AJCC 8th edition of TNM. Includes IASLC-original illustrations, beautifully rendered specifically for the iPad and smartphone media. Especially valuable to oncologists, surgeons, radiologists, scientists, and pathologists working in the field of thoracic oncology.

It is the IASLC's hope that the 8th edition of the Staging Classification will be a useful tool for further research and will serve in the daily lung cancer clinic to the benefit for the many patients around the world with lung cancer and other thoracic malignancies.

This app is sponsored by Lilly Oncology. Proceedings leading up to and culminating in the 8th edition of TNM staging classifications were funded by a grant from Eli Lilly and Company to IASLC for educational purposes only. The content is controlled and developed solely by IASLC. Lilly had no input into the proceedings or the TNM staging classifications.

Further assistance for this app is available from [email protected].

Was ist neu in der neuesten Version 4.2

Last updated on Apr 29, 2018

Added Chinese and Japanese version.

Übersetzung wird geladen...

Zusätzliche APP Informationen

Aktuelle Version

IASLC Staging Handbook Update anfordern 4.2

Von hochgeladen

李云康

Erforderliche Android-Version

Android 4.4+

Mehr anzeigen

IASLC Staging Handbook Screenshots

Sprachen
Abonnieren Sie APKPure
Erhalten Sie als der Erste den Zugang zu Vorabversionen, Neuigkeiten und Anleitungen der besten Android-Spiele und -Apps.
Nein, danke
Anmeldung
Erfolgreich abonniert!
Sie haben jetzt APKPure abonniert.
Abonnieren Sie APKPure
Erhalten Sie als der Erste den Zugang zu Vorabversionen, Neuigkeiten und Anleitungen der besten Android-Spiele und -Apps.
Nein, danke
Anmeldung
Erfolg!
Sie sind jetzt unseren Newsletter abonniert.